BRAF and colorectal cancer: In colorectal cancer, BRAF mutation is generally strongly associated with MSI-H, suggesting that MSI-H may be linked to a more favorable prognosis compared with microsatellite stability (MSS) within the BRAF mutation subgroup [13].